Foresee Pharmaceuticals Co., Ltd. (TPEX: 6576)

Foresee Pharmaceuticals Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 9, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	10,754	13,062	10,797	14,047	10,474	5,848
Market Cap Growth	14.79%	20.98%	-23.14%	34.12%	79.10%	16.51%
Enterprise Value	10,001	11,754	9,869	12,654	10,323	5,148
Last Close Price	79.10	96.20	90.39	118.19	88.61	56.77
PE Ratio	-	-11.82	-22.58	-24.37	-17.58	-11.18
PS Ratio	32.86	66.97	35.81	62.15	45.45	77.77
PB Ratio	10.75	10.50	11.86	10.64	5.73	6.53
P/FCF Ratio	-13.77	-13.99	-37.06	-63.80	-15.23	-10.94
P/OCF Ratio	-14.70	-14.72	-46.29	-65.85	-15.52	-13.06
EV/Sales Ratio	30.57	60.27	32.73	55.98	44.80	68.45
EV/EBITDA Ratio	-13.15	-12.36	-22.97	-25.39	-23.11	-11.60
EV/EBIT Ratio	-12.20	-11.67	-21.02	-23.49	-21.29	-10.95
EV/FCF Ratio	-12.13	-12.59	-33.88	-57.47	-15.01	-9.63
Debt / Equity Ratio	0.22	0.18	0.05	0.01	0.07	0.01
Debt / FCF Ratio	-0.27	-0.24	-0.14	-0.08	-0.19	-0.02
Asset Turnover	0.17	0.12	0.20	0.12	0.15	0.09
Inventory Turnover	1.16	0.53	0.25	1.73	1.54	0.30
Quick Ratio	2.10	2.65	5.54	17.12	13.45	8.03
Current Ratio	2.67	3.38	7.08	17.51	13.87	8.70
Return on Equity (ROE)	-61.48%	-96.17%	-42.37%	-36.15%	-37.48%	-69.88%
Return on Assets (ROA)	-27.45%	-39.79%	-19.92%	-18.00%	-19.49%	-35.97%
Return on Capital (ROIC)	-34.11%	-51.95%	-25.64%	-20.43%	-21.13%	-41.76%
Earnings Yield	-7.99%	-7.93%	-4.38%	-4.05%	-4.88%	-8.33%
FCF Yield	-7.66%	-7.15%	-2.70%	-1.57%	-6.56%	-9.14%
Buyback Yield / Dilution	-14.84%	-7.82%	-0.57%	-15.74%	-5.71%	-13.86%
Total Shareholder Return	-14.84%	-7.82%	-0.57%	-15.74%	-5.71%	-13.86%

Source: S&P Capital IQ. Standard template. Financial Sources.